Peripherex
Peripheral Vision Impairment Diagnosis and Monitoring Solution
Company Overview
Snapshot
Founded in January 2021 by Jeffrey Goldberg and Yitzi Kempinski, Peripherex operates with 1–10 employees. The company has raised $3 million across one funding round from one investor. In July 2021, Peripherex secured its Series A funding, with BIOLIGHT Life Sciences participating as a lead investor.
Business overview
Peripherex develops a software solution for diagnosing and monitoring peripheral vision impairment, both at home and in clinical settings. The company's core technology utilizes sophisticated eye-tracking software that runs on standard personal computers or tablets equipped with a built-in camera, eliminating the need for specialized hardware. This solution provides eye care professionals with tools to diagnose and monitor conditions such as glaucoma and other eye diseases, serving the digital healthcare and medical diagnostics sectors.
Log in to access full profile ›Company Intelligence Q&A
- When was Peripherex founded?
- Peripherex was founded in January 2021 by co-founders Jeffrey Goldberg and Yitzi Kempinski.
- What is Peripherex's primary focus?
- Peripherex focuses on developing software solutions for the diagnosis and monitoring of peripheral vision impairment, utilizing eye-tracking technology.
- What is Peripherex's product stage?
- Peripherex's product is currently in the Clinical Trial stage. The company's solution employs sophisticated eye-tracking software that runs on standard personal computers or tablets with a built-in camera, eliminating the need for additional hardware.
- What is the total capital raised by Peripherex?
- Peripherex has raised a total of $3 million across one funding round.
- Which investor participated in Peripherex's Series A funding round?
- In July 2021, BIOLIGHT Life Sciences participated as a lead investor in.